Is There Any Significant Difference in Stent Thrombosis Between Sirolimus and Paclitaxel Eluting Stents?: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Several meta-analyses have shown no significant difference in stent thrombosis (ST) between sirolimus eluting stents (SES) and paclitaxel eluting stents (PES). However, other meta-analyses have found SES to be superior to PES. Therefore, to solve this issue, we aim to compare the clinical outcomes b...
Main Authors: | Bundhun, Pravesh Kumar, Wu, Zi Jia, Chen, Meng-Hua |
---|---|
Format: | Online |
Language: | English |
Published: |
Wolters Kluwer Health
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748904/ |
Similar Items
-
Stent thrombosis and adverse cardiovascular outcomes observed between six months and five years with sirolimus-eluting stents and other drug-eluting stents in patients with Type 2 diabetes mellitus complicated by coronary artery disease: A systematic review and meta-analysis
by: Bundhun, Pravesh Kumar, et al.
Published: (2016) -
Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
by: Kim, Ung, et al.
Published: (2011) -
Head-to-Head Comparison of Sirolimus-Eluting Stents versus Paclitaxel-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of 76 Studies
by: Zhang, Xinlin, et al.
Published: (2014) -
Sirolimus-eluting coronary stents: a review
by: Abizaid, Alexandre
Published: (2007) -
Very Late Stent Thrombosis 42 Months after Implantation of Sirolimus-Eluting Stent and Discontinuation of Antiplatelet Therapy
by: Sibbing, Dirk, et al.
Published: (2009)